Chindex Reports Receiving Bid 20% Higher Than $360 Million Offer
This article was originally published in PharmAsia News
Chindex, a U.S.-based company whose United Family Healthcare network provides services in China, said it has received a new and higher acquisition offer from a company it did not identify.
You may also be interested in...
Generic OTC paracetamol and ibuprofen pack prices are gradually returning to pre-COVID levels, according to market analysts Wavedata. But a second wave could drive prices back up again.
Latest EU company news: Sanofi grows OTC portfolio in France and Italy with ColdZyme; Germany's WindStar Medical gets UK owners; and France's Ipsen continues to fell effects of COVID-19 on sales.
Combination of antibody therapy and Gilead's Veklury fails to show potential in patients with advanced disease.